Chronic Fatigue Syndrome Market Size
Market Size in USD Bn
CAGR5.4%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 5.4% |
| Market Concentration | High |
| Major Players | Hemispherx Biopharma, Inc., Cortene Inc., Mitsubishi Tanabe Pharma Corporation, NanoViricides, Inc., Tonix Pharmaceuticals Holding Corp. and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Chronic Fatigue Syndrome Market Analysis
The chronic fatigue syndrome market is estimated to be valued at USD 13.86 Bn in 2025 and is expected to reach USD 20.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032. Growing prevalence of chronic fatigue syndrome around the globe is the major factor driving the market's growth. Additionally, rising awareness regarding the availability of treatment is another important factor pushing the market upwards.